What is a steroid flare after an intra‑articular corticosteroid injection, and how should it be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Steroid Flare After Cortisone Joint Injection

A steroid flare is a transient increase in joint pain and inflammation occurring within 24-48 hours after intra-articular corticosteroid injection, affecting approximately 1 in 5 patients (20.7%), and is self-limited, typically resolving within 2-3 days without specific treatment beyond symptomatic management.

What Is a Steroid Flare?

A steroid flare (also called postinjection flare or pain flare) represents the most common adverse event following corticosteroid joint injections, accounting for approximately 75% of all complications 1. This phenomenon manifests as:

  • Acute worsening of pain at the injection site
  • Increased joint inflammation and warmth
  • Onset within 24-48 hours post-injection
  • Self-limited duration of 2-3 days in most cases

The incidence ranges from 4.6% to 20.7% across different studies 2, 1, making it a predictable and relatively common occurrence that patients should be counseled about during informed consent.

Clinical Characteristics and Risk Factors

Who Is at Higher Risk?

Younger patients face significantly higher risk of developing a steroid flare. Research demonstrates a 5.5% decreased odds of developing a flare per year of age (P < 0.01) 2. This means a 30-year-old patient has substantially higher risk than a 60-year-old receiving the same injection.

Subtalar joint injections carry independently higher risk compared to other joint locations 1.

What Does NOT Increase Risk?

Importantly, the following factors do not significantly affect flare risk 2:

  • Gender/sex
  • Body mass index (BMI)
  • Pre-injection pain severity
  • Type of corticosteroid used
  • Injection location (except subtalar joint)

Management Approach

Immediate Post-Injection Care

Avoid overuse of the injected joint for 24 hours following injection; however, immobilization is discouraged 3. This represents the key EULAR guideline recommendation for post-injection management.

Treatment of Active Flare

When a steroid flare occurs:

  • Reassure the patient this is a known, self-limited reaction
  • Apply ice to the affected joint for symptomatic relief
  • Use oral NSAIDs or acetaminophen for pain control if not contraindicated
  • Continue gentle range-of-motion exercises (avoid immobilization)
  • Monitor for 48-72 hours - most flares resolve spontaneously within this timeframe

Critical Distinction: Flare vs. Infection

You must differentiate a benign steroid flare from septic arthritis, though infection is exceedingly rare. Red flags for infection include:

  • Fever or systemic symptoms
  • Progressive worsening beyond 72 hours
  • Severe erythema and warmth
  • Joint effusion with purulent appearance

Note that no infections were reported in a large cohort of 1,708 ankle/subtalar injections 1, emphasizing the rarity of this complication.

Patient Counseling

Pre-Injection Discussion

Patients should be informed that:

  • 1 in 5 patients experience temporary pain increase after injection
  • Younger patients have higher risk of this reaction
  • Pain typically worsens within 24-48 hours then improves
  • This does not indicate infection or treatment failure
  • Most patients who obtain relief do so within 3 days (60.4%), and over 93.7% within one week 2

Setting Realistic Expectations

The therapeutic benefit timeline is important: while flares occur early, corticosteroid injections provide mild to moderate pain relief lasting up to 3 months 4, with effects approaching statistical insignificance at 4 months. This helps patients understand that temporary flare symptoms do not negate the overall treatment benefit.

Common Pitfalls to Avoid

  1. Do not immobilize the joint - this contradicts evidence-based guidelines 3
  2. Do not assume infection - steroid flares are far more common than septic arthritis
  3. Do not prescribe antibiotics empirically for typical flare presentations
  4. Do not dismiss younger patients' concerns - acknowledge their higher risk and provide extra counseling
  5. Do not repeat injection during active flare - wait for resolution and reassess benefit

The steroid flare represents a predictable, benign, and self-limited reaction that requires primarily supportive care and patient reassurance rather than aggressive intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.